Home > Healthcare > Biotechnology > Biotechnology R&D > Microcarriers Market

Microcarriers Market Size

  • Report ID: GMI8058
  • Published Date: Feb 2024
  • Report Format: PDF

Microcarriers Market Size

Microcarriers Market size was valued at USD 1.8 billion in 2023 and is anticipated to register a CAGR of over 9.5% between 2024 and 2032. The high market growth can be attributed to factors such as increasing cases of cancer and chronic diseases along with the advancements in cell culture technologies.

 

Also, rising investments in biotechnology & life sciences research activities, increasing focus on regenerative medicine, global need for vaccine production, and expanding stem cell therapy based research are few of the other factors driving the market growth. For instance, according to the WCRF International, there were an estimated 18.1 million cancer cases around the world in 2020.

 

The cancer research involving the cultivation and study of cancer cells in vitro to understand their behaviour, response to treatments, and molecular characteristics is expected to be on surge. Thus, microcarriers provide a platform for the efficient growth and expansion of cancer cells, supporting research efforts aimed at advancing to understand the disease, thereby driving the growth of the market.

 

Microcarriers are small, typically spherical particles or beads designed for use in cell culture and bioprocessing applications. These particles provide a surface for the attachment and growth of anchorage-dependent cells, allowing for the expansion of cell populations in a controlled environment. They are commonly used in bioreactors and other cell culture systems to support the production of cells for various purposes, including the manufacturing of biopharmaceuticals, vaccines, and cell-based therapies.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global microcarriers industry was valued at USD 1.8 billion in 2023 and is estimated to grow at a CAGR of 9.5% during the forecast period to reach USD 4 billion by 2032, driven by increasing cancer cases.

The biopharmaceutical production segment is expected to exhibit 9.6% CAGR between 2024-2032, as microcarriers provide a platform for efficient and scalable cell culture, supporting the growth of cells needed to produce biopharmaceuticals.

The size of the North America Microcarrier Market was valued at USD 730.1 million in 2023 and is expected to reach USD 1,602.3 million by 2032.

Bio-Rad Laboratories, Inc., Corning Incorporated, Cytiva, denovoMATRIX GmbH, Eppendorf AG, Fujiform Holdings Corporation, Lonza Group Ltd., Merck KGaA, Sartorious AG and Thermo Fisher Scientific Inc.

Microcarriers Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 518
  • Countries covered: 19
  • Pages: 230
 Download Free Sample